Takeda Sustainability Profile
Takeda Pharmaceutical Company Limited, commonly known as Takeda, is a leading global biopharmaceutical firm headquartered in Japan. Founded in 1781, Takeda has evolved into a prominent player in the pharmaceutical industry, with a strong presence in regions such as North America, Europe, and Asia. The company focuses on key therapeutic areas, including oncology, gastroenterology, neuroscience, and rare diseases, offering innovative treatments that address unmet medical needs. Takeda is renowned for its commitment to research and development, with a robust pipeline of biologics and small molecules. Notable achievements include its strategic acquisitions and partnerships that have bolstered its market position, making it one of the largest pharmaceutical companies in the world. With a dedication to patient-centric solutions, Takeda continues to lead in delivering unique therapies that improve health outcomes globally.
DitchCarbon Score
How does Takeda's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Takeda's score of 75 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Takeda's reported carbon emissions
In 2023, Takeda Pharmaceutical Company reported total carbon emissions of approximately 4,265,000,000 kg CO2e. This includes Scope 1 emissions of about 279,000,000 kg CO2e, Scope 2 emissions of approximately 33,000,000 kg CO2e (market-based), and a significant Scope 3 contribution of around 3,953,000,000 kg CO2e. The company has set ambitious targets to reduce its carbon footprint, aiming for a 30% reduction in CO2 emissions from energy sources by fiscal 2030, based on 2015 levels. Takeda has committed to achieving net-zero greenhouse gas emissions for Scopes 1 and 2 by 2035 and for its entire value chain, including Scope 3 emissions, by 2040. The company has also established near-term targets to reduce absolute Scope 1 and 2 emissions by 65% by FY2030 from a FY2016 baseline, and to cut Scope 3 emissions by 25% by FY2030 from a FY2022 baseline. Long-term goals include a 90% reduction in Scope 1 and 2 emissions by FY2035 and a 90% reduction in Scope 3 emissions by FY2040. These commitments align with the Science Based Targets initiative (SBTi) and reflect Takeda's dedication to sustainable practices within the pharmaceutical industry. The data presented is sourced directly from Takeda Pharmaceutical Company Limited, with no cascaded data from parent or related organizations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 96,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 161,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 3 | 226,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Takeda's Industry?
How Carbon Intensive is Takeda's Location?
Takeda's Scope 3 Categories Breakdown
Takeda's Scope 3 emissions, which decreased by 23% last year and increased significantly since 2015, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 68% of Scope 3 emissions.
Top Scope 3 Categories
Takeda's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Takeda has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Frequently Asked Questions
Common questions about Takeda's sustainability data and climate commitments